New Jersey AG: Janssen Falsely Claimed its Opioids Were Safer

Drug Industry Daily
A A
New Jersey’s attorney general claims Janssen falsely marketed its opioids Nucynta (tapentadol) and Nucynta ER as less addictive than other opioids in the state’s first such lawsuit against a Garden State-based drugmaker.

To View This Article:

Login

Subscribe To Drug Industry Daily